ObsEva competitorsClear all
BTG's top competitors include Zogenix, Clinigen Group and Durect.
| Save Comparison |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Clinigen Group A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | |
Founding Date | Founding Date 1948 | Founding Date 2006 | Founding Date 2010 | Founding Date N/A |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Emeryville, US HQ Windsor And Maidenhead, GB | Locations Burton upon Trent, GB HQ Warriewood, AU Chuo City, JP Singapore, SG Pretoria, ZA Hobson, GB London, GB see more | Locations Cupertino, US HQ | |
Employees | Employees N/A | Employees 9032% increase | Employees 465200% increase | Employees 885% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) 1.8 b | Valuation ($) 86.6 m |
Twitter followers | Twitter followers 1.1 k | Twitter followers 573 | Twitter followers 1.3 k | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) 31 | Number of tweets (last 30 days) 6 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 4.5 | Average likes per tweet (last 30 days) 7.3 | Average likes per tweet (last 30 days) 2 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 521342 | Alexa Website Rank 314146 | Alexa Website Rank 260657 | Alexa Website Rank 51017 |
Financial | ||||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) £456.9m (FY, 2019) | Revenue (est.) $18.6m (FY, 2018) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods N/A | Cost of goods £274.6m (FY, 2019) | Cost of goods $4.3m (FY, 2018) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit N/A | Gross profit £182.3m (FY, 2019) | Gross profit $14.3m (FY, 2018) |
Net income | Net income £88.3m (FY, 2019) | Net income ($123.9m) (FY, 2018) | Net income £5.2m (FY, 2019) | Net income ($25.3m) (FY, 2018) |
For sources of this data, please see the company profile
View company profiles
Zogenix
HQ
Emeryville, US
Employees
90↑ 32% increase
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyClinigen Group
HQ
Burton upon Trent, GB
Employees
465
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
View companyDurect
HQ
Cupertino, US
Employees
88↓ 5% decrease
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View company